Answers are grounded in this paper and cite their sources.
This early study demonstrates the presence of brain natriuretic peptide-like immunoreactivity in human plasma, laying the groundwork for its future use as a key cardiac biomarker.
A highly specific and sensitive radioimmunoassay (RIA) for a novel porcine brain natriuretic peptide (BNP) has been established to elucidate whether BNP-like immunoreactivity (LI) is present in human plasma. The antibody used was specific for BNP without any crossreactivities with known human atrial natriuretic peptides (hANP). After extraction of human plasma with Sep-Pak cartridge, this assay allowed for detection of BNP-LI as low as 0.1 fmol/tube. In 12 healthy subjects, the mean concentrations of plasma BNP-LI were 1.5 fmol/ml. Reverse-phase HPLC coupled with BNP RIA revealed that the single major component with BNP-LI, corresponding to porcine BNP(1 26), was apparently distinct from that of alpha-hANP. These data indicate that a small molecular mass form with BNP-LI circulates in human blood.
No takes yet. Share an insight, caveat, or question.
Togashi et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: